Opiate receptors and antagonists : from bench to clinic /
Saved in:
| Imprint: | New York, NY : Humana Press, c2009. |
|---|---|
| Description: | xxiii, 757 p., [6] p. of plates : ill. (some col.) ; 24 cm. |
| Language: | English |
| Series: | Contemporary neuroscience Contemporary neuroscience. |
| Subject: | |
| Format: | Print Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/7694252 |
MARC
| LEADER | 00000cam a22000004a 4500 | ||
|---|---|---|---|
| 001 | 7694252 | ||
| 005 | 20130312144200.0 | ||
| 008 | 081114s2009 njuaf b 001 0 eng | ||
| 003 | ICU | ||
| 010 | |a 2008941670 | ||
| 015 | |a GBA8B2373 |2 bnb | ||
| 015 | |a 014-76081 |2 bnb | ||
| 015 | |a GBA-8B237 |2 bnb | ||
| 016 | 7 | |a 101502381 |2 DNLM | |
| 016 | 7 | |a 014760812 |2 Uk | |
| 016 | 7 | |a 014-76081 |2 uk | |
| 016 | 7 | |a GBA-8B237 |2 uk | |
| 020 | |a 9781588298812 (alk. paper) | ||
| 020 | |a 1588298817 (alk. paper) | ||
| 020 | |a 9781597451970 (ebk.) | ||
| 020 | |a 1597451975 (ebk.) | ||
| 035 | |a (OCoLC)258094910 | ||
| 035 | |a yb2430850 | ||
| 040 | |a NLM |b eng |c NLM |d DLC |d UKM |d YDXCP |d CDX |d BWX |d LTL |d BTCTA |d VRC |d GBVCP |d IG# |d SOI | ||
| 042 | |a pcc | ||
| 049 | |a CGUA | ||
| 050 | 0 | 0 | |a QP552.E53 |b O642 2009 |
| 060 | 0 | 0 | |a 2009 D-967 |
| 060 | 1 | 0 | |a QV 89 |b O588 2009 |
| 082 | 0 | 4 | |a 615.7822 |2 22 |
| 084 | |a 15,3 |2 ssgn | ||
| 084 | |a 44.38 |2 bcl | ||
| 245 | 0 | 0 | |a Opiate receptors and antagonists : |b from bench to clinic / |c Reginald L. Dean III, Edward J. Bilsky, S. Stevens Negus, editors. |
| 260 | |a New York, NY : |b Humana Press, |c c2009. | ||
| 300 | |a xxiii, 757 p., [6] p. of plates : |b ill. (some col.) ; |c 24 cm. | ||
| 336 | |a text |b txt |2 rdacontent |0 http://id.loc.gov/vocabulary/contentTypes/txt | ||
| 337 | |a unmediated |b n |2 rdamedia |0 http://id.loc.gov/vocabulary/mediaTypes/n | ||
| 338 | |a volume |b nc |2 rdacarrier |0 http://id.loc.gov/vocabulary/carriers/nc | ||
| 490 | 1 | |a Contemporary neuroscience | |
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a Ultra-low-dose opioid antagonists enhance opioid analgesia and reduce tolerance / Lindsay H. Burns, Todd W. Vanderah, and Hoau-Yan Wang -- Upregulation of opioid receptors / Ellen M. Unterwald and Richard D. Howells -- Imaging human brain opioid receptors: applications to substance use disorders / Mark K. Greenwald and Caren L. Steinmiller -- Opioid receptor antagonist-mediated signaling in the immune system / Jonathan Moorman ... [et al.] -- The chemistry and pharmacology of [character omitted]-opioid antagonists / Jean M. Bidlack and Jennifer L. Mathews -- Medicinal chemistry of kappa opioid receptor antagonists / Cécile Béguin and Bruce M. Cohen -- The chemistry and pharmacology of delta opioid antagonists / Beatriz Fioravanti and Todd W. Vanderah -- Novel opioid antagonists with mixed/dual selectivity / Richard B. Rothman, Subramaniam Ananthan, and Edward J. Bilsky -- Experimental utility and clinical potential of irreversible opioid antagonists / Ellen A. Walker and Sandra D. Comer -- Methylnaltrexone: a peripherally acting opioid antagonist / Chun-Su Yuan and Robert J. Israel -- Opioid antagonist effects in animal models related to opioid abuse: drug discrimination and drug self-administration / S. Stevens Negus -- Naltrexone for initiation and maintenance of opiate abstinence / Kevin A. Sevarino and Thomas R. Kosten -- Ultra-low-dose naltrexone decreases dependence and addictive properties of opioids / Lindsay H. Burns, Francesco Leri, and Mary C. Olmstead -- Can a combination formulation containing a neutral opiate antagonist decrease the abuse of [character omitted]-agonist opiates / John Mendelson, Mark Pletcher, and Gantt Galloway -- Effects of opioid antagonists on the abuse-related effects of psychomotor stimulants and nicotine / Brenda J. Gehrke and Toni S. Shippenberg -- Potential use of opioid antagonists in the treatment of marijuana abuse and dependence / Bernard Le Foll ... [et al.] -- Naltrexone in smoking cessation: a review of the literature and future directions / Andrea King ... [et al.] -- Opioid antagonists and ethanol's ability to reinforce intake of alcoholic beverages: preclinical studies / Larry D. Reid -- Clinical use of opioid antagonists in the treatment of alcohol dependence / Raymond F. Anton -- Preclinical effects of opioid antagonists on feeding and appetite / Richard J. Bodnar -- CNS opiate systems and eating disorders / Elliot D. Luby and David Koval -- Potential utility of kappa ligands in the treatment of mood disorders / William A. Carlezon, Jr. and Bruce M. Cohen -- Opioid antagonists in the treatment of pathological gambling and kleptomania / Jon E. Grant -- Efficacy of opioid antagonists in attentuating self-injurious behavior / Curt A. Sandman -- Pharmacotherapeutic effects of opioid antagonists in alcohol-abusing patients with schizophrenia / Ismene Petrakis -- Current issues in the use of opioid antagonists (naltrexone for opiate abuse: a re-educational tool as well as an effective drug) / Colin Brewer and Emmanuel Streel -- Emergency room use of opioid antagonists in drug intoxication and overdose / Simon F.J. Clarke ... [et al.] -- Kappa-opioid antagonists as pruritogenic agents / Alan Cowan and Saadet Inan -- Clinical effect of opioid antagonists on clinical pruritus / Nora V. Bergasa -- Effects of opioid antagonists on [subscript L]-DOPA-induced dyskinesia in Parkinson's disease / Susan H. Fox, Tom H. Johnston, and Jonathan M. Brotchie -- Endocrine effects of opioid antagonists / Jack H. Mendelson and Nancy K. Mello -- Opioid antagonists in traumatic shock: animal and human studies / Liangming Liu -- The efficacy of opioid antagonists against heatstroke-induced ischemia and injury in rats / Mao-Tsun Lin, Ching-Ping Chang, and Sheng-Hsien Chen -- A review of the opioid system in cancer patients and preliminary results of opioid antagonists in the treatment of human neoplasms / Paolo Lissoni -- Nonclinical pharmacology of VIVITROL®: a monthly injectable naltrexone for treatment of alcohol dependence / Reginald L. Dean, III -- The development of sustained-release naltrexone and clinical use in treating opiate dependence / Gary K. Hulse, Sandra D. Comer, and Maria A. Sullivan -- The development of ProNeura technology for the treatment of addictions / Lauren C. Costantini -- Development of opioid transdermal delivery systems / Kalpana S. Paudel ... [et al.] -- Intranasal naloxone for treatment of opioid overdose / Anne-Maree Kelly, Debra Kerr, and Paul Dietze. | |
| 650 | 0 | |a Endorphins |x Receptors. |0 http://id.loc.gov/authorities/subjects/sh85043095 | |
| 650 | 0 | |a Endorphins |x Antagonists. | |
| 650 | 0 | |a Opioids |x Receptors. |0 http://id.loc.gov/authorities/subjects/sh85095086 | |
| 650 | 0 | |a Nervous system |x Diseases |x Chemotherapy. | |
| 650 | 2 | |a Narcotic Antagonists |x therapeutic use. | |
| 650 | 2 | |a Drug Delivery Systems. | |
| 650 | 2 | |a Drug Discovery. | |
| 650 | 2 | |a Opioid Peptides. | |
| 650 | 2 | |a Receptors, Opioid. | |
| 650 | 2 | |a Substance-Related Disorders |x drug therapy. | |
| 653 | 0 | |a Endorphins |a Antagonists | |
| 653 | 0 | |a Endorphins |a Receptors | |
| 653 | 0 | |a Nervous system |a Diseases |a Chemotherapy | |
| 650 | 7 | |a Endorphins |x Receptors. |2 fast |0 http://id.worldcat.org/fast/fst00909806 | |
| 650 | 7 | |a Nervous system |x Diseases |x Chemotherapy. |2 fast |0 http://id.worldcat.org/fast/fst01036100 | |
| 650 | 7 | |a Opioids |x Receptors. |2 fast |0 http://id.worldcat.org/fast/fst01046546 | |
| 700 | 1 | |a Dean, Reginald L. |0 http://id.loc.gov/authorities/names/n99800416 |1 http://viaf.org/viaf/86201119 | |
| 700 | 1 | |a Bilsky, Edward J. |0 http://id.loc.gov/authorities/names/n2009182037 |1 http://viaf.org/viaf/88425626 | |
| 700 | 1 | |a Negus, S. Stevens. |0 http://id.loc.gov/authorities/names/n2009182038 |1 http://viaf.org/viaf/88425635 | |
| 830 | 0 | |a Contemporary neuroscience. |0 http://id.loc.gov/authorities/names/n83708124 | |
| 903 | |a HeVa | ||
| 929 | |a cat | ||
| 999 | f | f | |i 33781cb5-c8d9-502d-8f40-a2fd5dcf008e |s 5bf85de6-694e-5ea1-a371-cc529cf6a74d |
| 928 | |t Library of Congress classification |a QP552.E53 O642 2009 |l JCL |c JCL-Sci |i 5466091 | ||
| 927 | |t Library of Congress classification |a QP552.E53 O642 2009 |l JCL |c JCL-Sci |e CRERAR |b 088666385 |i 8586532 | ||
